Rebecca L Ashare1, Larry W Hawk. 1. Department of Psychology, University at Buffalo, SUNY, 206 Park Hall, Buffalo, NY 14260, USA. rlashare@buffalo.edu
Abstract
RATIONALE: Impulsivity, a multifaceted construct that includes inhibitory control and heightened preference for immediate reward, is central to models of drug use and abuse. Within a self-medication framework, abstinence from smoking may lead to an increase in impulsive behavior and the likelihood of relapse, particularly among persons with disorders (e.g., attention-deficit/hyperactivity disorder, ADHD) and personality traits (e.g., impulsivity) linked to impulsive behavior. OBJECTIVES: This study aimed to examine the effects of smoking abstinence on multiple measures of impulsivity among a non-clinical sample of adult smokers selected for high and low levels of ADHD symptoms. METHODS: In a within-subjects design, participants selected for high or low levels of self-reported ADHD symptoms (N = 56) completed sessions following overnight abstinence and when smoking as usual (order counterbalanced). Measures of impulsive behavior included response inhibition (i.e., stop signal task), interference control (i.e., attentional modification of prepulse inhibition (PPI) of startle), and impulsive choice (i.e., hypothetical delay discounting). RESULTS: As hypothesized, abstinence decreased response inhibition and PPI. Although ADHD symptoms moderated abstinence effects on impulsive choice and response inhibition, the pattern was opposite to our predictions: the low-ADHD group responded more impulsively when abstinent, whereas the high-ADHD group was relatively unaffected by abstinence. CONCLUSIONS: These findings highlight the importance of utilizing multiple laboratory measures to examine a multifactorial construct such as impulsive behavior and raise questions about how best to assess symptoms of ADHD and impulsivity among non-abstinent smokers.
RATIONALE: Impulsivity, a multifaceted construct that includes inhibitory control and heightened preference for immediate reward, is central to models of drug use and abuse. Within a self-medication framework, abstinence from smoking may lead to an increase in impulsive behavior and the likelihood of relapse, particularly among persons with disorders (e.g., attention-deficit/hyperactivity disorder, ADHD) and personality traits (e.g., impulsivity) linked to impulsive behavior. OBJECTIVES: This study aimed to examine the effects of smoking abstinence on multiple measures of impulsivity among a non-clinical sample of adult smokers selected for high and low levels of ADHD symptoms. METHODS: In a within-subjects design, participants selected for high or low levels of self-reported ADHD symptoms (N = 56) completed sessions following overnight abstinence and when smoking as usual (order counterbalanced). Measures of impulsive behavior included response inhibition (i.e., stop signal task), interference control (i.e., attentional modification of prepulse inhibition (PPI) of startle), and impulsive choice (i.e., hypothetical delay discounting). RESULTS:As hypothesized, abstinence decreased response inhibition and PPI. Although ADHD symptoms moderated abstinence effects on impulsive choice and response inhibition, the pattern was opposite to our predictions: the low-ADHD group responded more impulsively when abstinent, whereas the high-ADHD group was relatively unaffected by abstinence. CONCLUSIONS: These findings highlight the importance of utilizing multiple laboratory measures to examine a multifactorial construct such asimpulsive behavior and raise questions about how best to assess symptoms of ADHD and impulsivity among non-abstinent smokers.
Authors: Rebecca L Ashare; Larry W Hawk; Keri Shiels; Jessica D Rhodes; William E Pelham; James G Waxmonsky Journal: Psychophysiology Date: 2010-03-10 Impact factor: 4.016
Authors: Kevin G Volpp; Andrea B Troxel; Mark V Pauly; Henry A Glick; Andrea Puig; David A Asch; Robert Galvin; Jingsan Zhu; Fei Wan; Jill DeGuzman; Elizabeth Corbett; Janet Weiner; Janet Audrain-McGovern Journal: N Engl J Med Date: 2009-02-12 Impact factor: 91.245
Authors: Annette Conzelmann; Paul Pauli; Ronald F Mucha; Christian P Jacob; Antje B M Gerdes; Jasmin Romanos; Christina G Bähne; Monika Heine; Andrea Boreatti-Hümmer; Georg W Alpers; Andreas J Fallgatter; Andreas Warnke; Klaus-Peter Lesch; Peter Weyers Journal: J Abnorm Psychol Date: 2010-08
Authors: Keri Shiels; Larry W Hawk; Brady Reynolds; Rebecca J Mazzullo; Jessica D Rhodes; William E Pelham; James G Waxmonsky; Brian P Gangloff Journal: Exp Clin Psychopharmacol Date: 2009-10 Impact factor: 3.157
Authors: Eldon T Mueller; Reid D Landes; Benjamin P Kowal; Richard Yi; Maxine L Stitzer; Cody A Burnett; Warren K Bickel Journal: Behav Pharmacol Date: 2009-09 Impact factor: 2.293
Authors: K K Higa; A Grim; M E Kamenski; J van Enkhuizen; X Zhou; K Li; J C Naviaux; L Wang; R K Naviaux; M A Geyer; A Markou; J W Young Journal: Psychopharmacology (Berl) Date: 2017-02-28 Impact factor: 4.530
Authors: Alexander Weigard; Cynthia Huang-Pollock; Andrew Heathcote; Larry Hawk; Nicolas J Schlienz Journal: Psychopharmacology (Berl) Date: 2018-09-04 Impact factor: 4.530
Authors: John R Smethells; Natashia L Swalve; Lynn E Eberly; Marilyn E Carroll Journal: Psychopharmacology (Berl) Date: 2016-06-20 Impact factor: 4.530
Authors: Scott R Vrana; Patrick S Calhoun; Michelle F Dennis; Angela C Kirby; Jean C Beckham Journal: J Psychopharmacol Date: 2015-08-07 Impact factor: 4.153